Challenge the current pediatric blood cancer landscape
In the current era of targeted and immuno-oncology drugs being developed in adults, very few successful examples have been translated to childhood blood cancer treatment. Clear advances have occurred, but cure rates remain low for certain blood cancer types, along with considerable long-term effects from traditional therapies. For the benefit of children, a better understanding of tumor biology and further progress in drug development and treatment are needed.
Grant Details
The LLSC’s Pediatric Blood Cancer Research Innovation Grant is a two-year grant designed to provide funding to research that will lead to a significant change in the understanding, diagnosis, or treatment of pediatric blood cancers.
The LLSC will provide funding for up to 5 grants up to a maximum of $100,000 per year for two years (up to a maximum total of $200,000 for the two years). Kindred Foundation has generously committed to co-fund two (2) grants within the competition.
How to apply
The application process will occur in two phases. The first phase is submission and consideration of a Letter of Intent (LOI). The second phase is the invitation for and submission of a Full Application. The applicant must register with the LLSC Research Portal, Proposal Central in order to apply. Both the LOI and the Full Application must be submitted electronically to the LLSC Research Portal.
Funds for competitive applications will be awarded on the basis of scientific merit, using a priority rating system.
Key dates for 2021-2022
- Call for Proposals: Nov 1, 2021
- Letter of Intent (LOI) due: Dec 8, 2021, 4:00 pm (EST)
- Notification of Full Application Invite: Dec 2021
- Full application deadline: February 4, 2022, 4:00 pm EST
- Review Panel Meeting: April 2022
- Notification of Awards: May 2022
- Award Start Date: July 2022
Read the guidelines
Applicants must carefully read the program guidelines before beginning their applications.
Download – LLSC Pediatric Blood Cancer Research Innovation Grant Guidelines & Instructions
Download – LLSC Pediatric Blood Cancer Research Innovation Grant Policies and Procedures
Submitting a letter of intent
Submitting a Letter of Intent is mandatory for all applicants.
Submit your letter of intent here.
This grant is endorsed by:
Advocacy for Canadian Childhood Oncology Research Network (Ac2orn)
Childhood Cancer Canada
C17 - Children's Cancer & Blood Disorders